This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1976.
Company Filing History:
1 out of 834,411 Years Active: 1976
Title: Chiyoji Abe: Innovator in Vaccine Development
Introduction
Chiyoji Abe is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical science, particularly in the development of vaccines. His innovative work focuses on preventing infections caused by Pseudomonas aeruginosa, a bacterium known for its resistance to antibiotics.
Latest Patents
Chiyoji Abe holds a patent for a method aimed at preventing Pseudomonas aeruginosa infections. The patent describes vaccine preparations that comprise a cell wall protein component of Pseudomonas aeruginosa as the active ingredient, along with a pharmaceutically acceptable carrier. These preparations are designed for parenteral administration, providing a prophylactic treatment for diseases caused by this bacterium. The cell wall protein component is characterized by its low toxicity and lack of type-specificity to the various antigens of Pseudomonas aeruginosa. He has 1 patent to his name.
Career Highlights
Throughout his career, Chiyoji Abe has focused on innovative solutions to combat bacterial infections. His work has been instrumental in advancing vaccine technology, particularly in addressing the challenges posed by antibiotic-resistant bacteria.
Collaborations
Chiyoji Abe has collaborated with notable colleagues in his field, including Hiroshi Shionoya and Yuzuru Homma. Their combined expertise has contributed to the development of effective vaccine strategies.
Conclusion
Chiyoji Abe's contributions to vaccine development highlight the importance of innovation in combating infectious diseases. His work continues to pave the way for advancements in medical science and public health.